Ozempic, a GLP-1 receptor agonist, has officially launched in India, offering a new treatment option for type 2 diabetes.

Novo Nordisk has launched its diabetes medication Ozempic in India, a significant move amid increasing demand for diabetes and weight management solutions. , Companies, Times Now ...

Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs ...

FDA may expedite approval timeline for Eli Lilly's weight-loss treatment, potentially moving decision date to late March from ...

The GLP-1 receptor agonist is approved in India as an adjunct to diet and exercise for adults with type 2 diabetes ...

Early results from the OLYMPIA-3 trial reveal odronextamab plus CHOP chemotherapy shows promising efficacy for untreated ...

Ozempic is finally here — but it doesn’t come cheap. With costs touching ₹11,000 a month and generics still a year away, here ...

There’s been a lot of buzz about magnesium on social media lately, including “hacks” for the best time to take it. But does ...

Doctors typically begin patients on 0.25 mg once a week for the first month. After the introductory phase, the dosage ...

Delhi Development Authority (DDA) demolished a bungalow in the Sainik Farm area as part of its anti-encroachment drive on Dec ...

Amid a swell of regulatory successes in the myasthenia gravis arena this decade, Amgen is wading into the fray with a new ...

Immunovant shifts primary focus to IMVT-1402, a next-generation anti-FcRn, targeting Graves' Disease with potential ...